The Effects of Programmed Administration of Human Parathyroid Hormone Fragment (1-34) on Bone Histomorphometry and Serum Chemistry in Rats
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
PTH treatment can result in dramatic increases in cancellous bone volume in normal and osteopenic rats. However, this potentially beneficial response is only observed after pulsatile treatment; continuous infusion of PTH leads to hypercalcemia and bone abnormalities. The purpose of these studies was to determine the optimal duration of the PTH pulses. A preliminary study revealed that human PTH-(1-34) (hPTH) is cleared from circulation within 6 h after sc administration of an anabolic dose of the hormone (80 microg/kg). To establish the effects of gradually extending the duration of exposure to hPTH without increasing the daily dose, we programmed implanted Alzet osmotic pumps to deliver the 80 microg/kg x day dose of the hormone during pulses of 1, 2, and 6 h/day, or 40 microg/kg x day continuously. Discontinuous infusion was accomplished by alternate spacing of external tubing with hPTH solution and sesame oil. After 6 days of treatment, we evaluated serum chemistry and bone histomorphometry. As negative and positive controls, groups of rats received pumps that delivered vehicle only and 80 microg/kg x day hPTH by daily sc injection, respectively. Dynamic and static bone histomorphometry revealed that the daily sc injection and 1 h/day infusion dramatically increased osteoblast number and bone formation in the proximal tibial metaphysis, whereas longer infusion resulted in systemic side-effects, including up to a 10% loss in body weight, hypercalcemia, and histological changes in the proximal tibia resembling abnormalities observed in patients with chronic primary hyperparathyroidism, including peritrabecular marrow fibrosis and focal bone resorption. Infusion for as little as 2 h/day resulted in minor weight loss and changes in bone histology that were intermediate between sc and continuous administration. The results demonstrate that the therapeutic interval for hPTH exposure is brief, but that programmed administration of implanted hormone is a feasible alternative to daily injection as a route for administration of the hormone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parfitt, A. M., Mathews, C. H., Villanueva, A. R., Kleerekoper, M., Frame, B., & Rao, D. S. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111096 · Cited by 1,545
Anabolic Actions of Parathyroid Hormone on Bone*
DEMPSTER, D. W., COSMAN, F., PARISIEN, M., SHEN, V., & LINDSAY, R. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-6-690 · Cited by 717
Dobnig, H. (1995) · Endocrinology · doi:10.1210/en.136.8.3632 · Cited by 615
Self-citationTAM, C. S., HEERSCHE, J. N. M., MURRAY, T. M., & PARSONS, J. A. (1982) · Endocrinology · doi:10.1210/endo-110-2-506 · Cited by 612
Wronski, T. J. (1993) · Endocrinology · doi:10.1210/en.132.2.823 · Cited by 290
Human Parathyroid Hormone-(l–34) Increases Bone Mass in Ovariectomized and Orchidectomized Rats*
HOCK, J. M., GERA, I., FONSECA, J., & RAISZ, L. G. (1988) · Endocrinology · doi:10.1210/endo-122-6-2899 · Cited by 240
Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone
Gunness-Hey, M., & Hock, J. M. (1984) · Metabolic Bone Disease and Related Research · doi:10.1016/0221-8747(84)90026-2 · Cited by 216
Dr. Liu, C.-C., & Kalu, D. N. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650050911 · Cited by 203
Leaffer, D., Sweeney, M., Kellerman, L., Avnur, Z., Krstenansky, J. L., VICKERY, B. H., & CAULFIELD, J. P. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628402 · Cited by 128
Hori, M., Uzawa, T., Morita, K., Noda, T., Takahashi, H., & Inoue, J. (1988) · PubMed · Cited by 113
Anabolic Effect of Human Synthetic Parathyroid Hormone-(1-34) Depends on Growth Hormone*
Hock, J. M., & Fonseca, J. (1990) · Endocrinology · doi:10.1210/endo-127-4-1804 · Cited by 78
Ma, Y. F., Jee, W. S. S., Ke, H. Z., Lin, B. Y., Liang, X. G., Li, M., & Yamamoto, N. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100322 · Cited by 70
Southwestern Internal Medicine Conference: Normal and Abnormal Regulation of 1,25-(OH)2D Synthesis
Breslau, N. A. (1988) · The American Journal of the Medical Sciences · doi:10.1097/00000441-198812000-00009 · Cited by 58
Modulation of ovariectomy-related bone loss by parathyroid hormone in rats
Kalu, D. N., Echon, R., & Hollis, B. W. (1990) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(90)90114-u · Cited by 55
Cited by
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Therapeutic Approaches to Bone Diseases
Rodan, G. A., & Martin, T. J. (2000) · Science · doi:10.1126/science.289.5484.1508 · Cited by 1,767
Molecular and cellular mechanisms of the anabolic effect of intermittent PTH
Jilka, R. L. (2007) · Bone · doi:10.1016/j.bone.2007.03.017 · Cited by 720
SOST is a target gene for PTH in bone
Keller, H., & Kneissel, M. (2005) · Bone · doi:10.1016/j.bone.2005.03.018 · Cited by 616
Parathyroid hormone: anabolic and catabolic actions on the skeleton
Silva, B. C., & Bilezikian, J. P. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.03.005 · Cited by 557
Metadata
- Authors
- Dobnig, H.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1997-11-01
- Volume
- 138
- Issue
- 11
- Pages
- 4607-4612
- ISSN
- 0013-7227 (ISSN-L)
- OpenAlex
- W2062496249
- Cited by
- 322
- References
- 15
- FWCI
- 4.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.